Audentes Therapeutics Stock Rocketed On Gene Therapy Trial In … – Investor’s Business Daily
Investor’s Business Daily |
Audentes Therapeutics Stock Rocketed On Gene Therapy Trial In …
Investor’s Business Daily Audentes rocketed to an all-time high as its gene therapy showed promising results in treating a muscular disorder. Audentes' gene therapy AT132 shows positive effect in XLMTM study; shares ahead 13% premarket BOLD | Stocks Latest Headlines for Audentes Therapeutics Inc – Barchart.com |
